| Income Statement |
| Operating Expenses | 7.56M |
|
| Research and Development Expense | 5.26M |
| Selling, General and Administrative Expense | 1.72M |
| Operating Income | -7.56M |
| Net Income | -7.32M |
| Net Income Common Stock | -7.32M |
| Net Income Common Stock (USD) | -5.31M |
| Consolidated Income | -7.32M |
| Earnings per Basic Share | -0.11 |
| Earnings per Basic Share (USD) | -0.08 |
| Earnings per Diluted Share | -0.11 |
| Earning Before Interest & Taxes (EBIT) | -7.32M |
| Earning Before Interest & Taxes (USD) | -5.31M |
| Weighted Average Shares | 67.00M |
| Weighted Average Shares Diluted | 67.00M |
| Balance Sheet |
| Cash and Equivalents | 32.31M |
| Cash and Equivalents (USD) | 23.41M |
| Trade and Non-Trade Receivables | 499.68K |
| Current Assets | 34.87M |
| Property, Plant & Equipment Net | 14.38M |
| Total Assets | 49.25M |
| Current Liabilities | 2.97M |
| Total Liabilities | 2.97M |
| Accumulated Retained Earnings (Deficit) | -77.81M |
| Shareholders Equity | 46.28M |
| Shareholders Equity (USD) | 33.54M |
| Assets Non-Current | 14.38M |
| Trade and Non-Trade Payables | 2.97M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.23K |
| Net Cash Flow from Financing | 933.53K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.89M |
| Capital Expenditure | -16.33K |
| Issuance (Purchase) of Equity Shares | 933.53K |
| Net Cash Flow from Investing | -16.33K |
| Net Cash Flow from Operations | -6.81M |
| Effect of Exchange Rate Changes on Cash | 2.43K |
| Share Based Compensation | 563.51K |